Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome
暂无分享,去创建一个
U. Fuhr | M. Hallek | K. Kreuzer | F. Farowski | O. Cornely | J. Vehreschild | V. Kohl | C. Müller | M. Vehreschild